Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation
by
Sanclimens, Glòria
, Scheper, Johanna
, Guerra-Rebollo, Marta
, Blanco, Jerónimo
, Rubio, Nuria
, González-Ruiz, Domingo
, Ortiz, Angel R.
, Plans, Vanessa
, Morreale, Antonio
, Moure, Alejandra
, Thomson, Timothy M.
, Crosas, Bernat
, Messeguer, Àngel
, Loukili, Noureddine
, Masip, Isabel
, Meca-Cortés, Óscar
in
Activation
/ Animals
/ Antagonists
/ Biological effects
/ Catalysis
/ Cell Biology/Cell Signaling
/ Cell survival
/ Cells (Biology)
/ Chemical Biology
/ Chemical compounds
/ Chemotherapy
/ Combinatorial analysis
/ Damage tolerance
/ Deoxyribonucleic acid
/ DNA
/ DNA damage
/ DNA repair
/ Drug resistance
/ Enzymatic activity
/ HeLa Cells
/ Humans
/ In vivo methods and tests
/ Inhibitors
/ Invasiveness
/ Kinases
/ Lysine
/ Mammalian cells
/ Medical screening
/ Mice
/ Models, Animal
/ Models, Molecular
/ NF-kappa B - metabolism
/ NF-κB protein
/ Oncology
/ Pharmacology
/ Proliferating cell nuclear antigen
/ Prostate cancer
/ Protein Binding
/ Protein interaction
/ Protein-protein interactions
/ Proteins
/ Proteins - metabolism
/ Saccharomyces cerevisiae
/ Stem cells
/ Stress management
/ Tagging
/ Therapeutic applications
/ Tumor cells
/ Tumor necrosis factor-TNF
/ Tumor necrosis factor-α
/ Ubiquitin
/ Ubiquitination
2010
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation
by
Sanclimens, Glòria
, Scheper, Johanna
, Guerra-Rebollo, Marta
, Blanco, Jerónimo
, Rubio, Nuria
, González-Ruiz, Domingo
, Ortiz, Angel R.
, Plans, Vanessa
, Morreale, Antonio
, Moure, Alejandra
, Thomson, Timothy M.
, Crosas, Bernat
, Messeguer, Àngel
, Loukili, Noureddine
, Masip, Isabel
, Meca-Cortés, Óscar
in
Activation
/ Animals
/ Antagonists
/ Biological effects
/ Catalysis
/ Cell Biology/Cell Signaling
/ Cell survival
/ Cells (Biology)
/ Chemical Biology
/ Chemical compounds
/ Chemotherapy
/ Combinatorial analysis
/ Damage tolerance
/ Deoxyribonucleic acid
/ DNA
/ DNA damage
/ DNA repair
/ Drug resistance
/ Enzymatic activity
/ HeLa Cells
/ Humans
/ In vivo methods and tests
/ Inhibitors
/ Invasiveness
/ Kinases
/ Lysine
/ Mammalian cells
/ Medical screening
/ Mice
/ Models, Animal
/ Models, Molecular
/ NF-kappa B - metabolism
/ NF-κB protein
/ Oncology
/ Pharmacology
/ Proliferating cell nuclear antigen
/ Prostate cancer
/ Protein Binding
/ Protein interaction
/ Protein-protein interactions
/ Proteins
/ Proteins - metabolism
/ Saccharomyces cerevisiae
/ Stem cells
/ Stress management
/ Tagging
/ Therapeutic applications
/ Tumor cells
/ Tumor necrosis factor-TNF
/ Tumor necrosis factor-α
/ Ubiquitin
/ Ubiquitination
2010
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation
by
Sanclimens, Glòria
, Scheper, Johanna
, Guerra-Rebollo, Marta
, Blanco, Jerónimo
, Rubio, Nuria
, González-Ruiz, Domingo
, Ortiz, Angel R.
, Plans, Vanessa
, Morreale, Antonio
, Moure, Alejandra
, Thomson, Timothy M.
, Crosas, Bernat
, Messeguer, Àngel
, Loukili, Noureddine
, Masip, Isabel
, Meca-Cortés, Óscar
in
Activation
/ Animals
/ Antagonists
/ Biological effects
/ Catalysis
/ Cell Biology/Cell Signaling
/ Cell survival
/ Cells (Biology)
/ Chemical Biology
/ Chemical compounds
/ Chemotherapy
/ Combinatorial analysis
/ Damage tolerance
/ Deoxyribonucleic acid
/ DNA
/ DNA damage
/ DNA repair
/ Drug resistance
/ Enzymatic activity
/ HeLa Cells
/ Humans
/ In vivo methods and tests
/ Inhibitors
/ Invasiveness
/ Kinases
/ Lysine
/ Mammalian cells
/ Medical screening
/ Mice
/ Models, Animal
/ Models, Molecular
/ NF-kappa B - metabolism
/ NF-κB protein
/ Oncology
/ Pharmacology
/ Proliferating cell nuclear antigen
/ Prostate cancer
/ Protein Binding
/ Protein interaction
/ Protein-protein interactions
/ Proteins
/ Proteins - metabolism
/ Saccharomyces cerevisiae
/ Stem cells
/ Stress management
/ Tagging
/ Therapeutic applications
/ Tumor cells
/ Tumor necrosis factor-TNF
/ Tumor necrosis factor-α
/ Ubiquitin
/ Ubiquitination
2010
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation
Journal Article
Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation
2010
Request Book From Autostore
and Choose the Collection Method
Overview
Several pathways that control cell survival under stress, namely RNF8-dependent DNA damage recognition and repair, PCNA-dependent DNA damage tolerance and activation of NF-kappaB by extrinsic signals, are regulated by the tagging of key proteins with lysine 63-based polyubiquitylated chains, catalyzed by the conserved ubiquitin conjugating heterodimeric enzyme Ubc13-Uev.
By applying a selection based on in vivo protein-protein interaction assays of compounds from a combinatorial chemical library followed by virtual screening, we have developed small molecules that efficiently antagonize the Ubc13-Uev1 protein-protein interaction, inhibiting the enzymatic activity of the heterodimer. In mammalian cells, they inhibit lysine 63-type polyubiquitylation of PCNA, inhibit activation of NF-kappaB by TNF-alpha and sensitize tumor cells to chemotherapeutic agents. One of these compounds significantly inhibited invasiveness, clonogenicity and tumor growth of prostate cancer cells.
This is the first development of pharmacological inhibitors of non-canonical polyubiquitylation that show that these compounds produce selective biological effects with potential therapeutic applications.
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.